Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Introducing the Group for Research of Policy Dynamics in Dermatology: "Future considerations for clinical dermatology in the setting of 21st century American policy reform" manuscript series.
Nguyen HP, Barbieri JS, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology. Nguyen HP, et al. Among authors: barbieri js. J Am Acad Dermatol. 2017 Jan;76(1):168-169. doi: 10.1016/j.jaad.2016.02.1247. Epub 2016 Oct 1. J Am Acad Dermatol. 2017. PMID: 27707592 No abstract available.
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System.
Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology. Barbieri JS, et al. J Am Acad Dermatol. 2017 Jun;76(6):1206-1212. doi: 10.1016/j.jaad.2017.01.032. Epub 2017 Mar 30. J Am Acad Dermatol. 2017. PMID: 28365038
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology.
Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology. Barbieri JS, et al. J Am Acad Dermatol. 2017 Jun;76(6):1213-1217. doi: 10.1016/j.jaad.2017.01.031. Epub 2017 Mar 30. J Am Acad Dermatol. 2017. PMID: 28365040
Commentary: Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and CHIP Reauthorization Act of 2015.
Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology. Barbieri JS, et al. J Am Acad Dermatol. 2017 Jun;76(6):1203-1205. doi: 10.1016/j.jaad.2017.01.033. Epub 2017 Mar 30. J Am Acad Dermatol. 2017. PMID: 28365041 No abstract available.
Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment.
Albrecht J, Adamson AS, Barbieri JS, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM; American Academy of Dermatology Association Task Force on Drug Pricing and Transparency. Albrecht J, et al. Among authors: barbieri js. J Am Acad Dermatol. 2019 Feb;80(2):577-578. doi: 10.1016/j.jaad.2018.09.016. Epub 2018 Sep 20. J Am Acad Dermatol. 2019. PMID: 30244066 Review. No abstract available.
Evaluating the cost-effectiveness of teledermatology.
Barbieri JS, Yang X, Kovarik CL. Barbieri JS, et al. J Am Acad Dermatol. 2019 Sep;81(3):765-766. doi: 10.1016/j.jaad.2018.06.074. Epub 2018 Oct 1. J Am Acad Dermatol. 2019. PMID: 30287327 No abstract available.
185 results